Skip to main content

Table 2 Clinical parameters of platelets from healthy donors and lung cancer patients

From: MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3

 

Sample number

PLT (×10 9 /L)

PCT (%)

MPV (fl)

PDW (%)

Healthy

20

212.53 ± 45.41

0.2095 ± 0.09

8.35 ± 1.35

14.9 ± 1.75

NSCLC

20

268.47 ± 73.62***

0.2694 ± 0.04**

9.65 ± 1.9

16.4 ± 1.50

  1. PLT, platelets; PCT, Platelet hematocrit; MPV, Mean platelet volume; PDW, platelet distribution width; Statistical comparison was performed by using Student’s t-test (*, P < 0.05, **, P < 0.01, ***, P < 0.001).